Financial statements Optipharm
Balance sheet data of OPTIPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 142 014,32 | 388 925,63 | 373 874,13 | 376 395,23 | 416 315,22 |
| A. Fixed assets | 7 722,25 | 210 000,00 | 210 000,00 | 375 243,38 | 414 692,37 |
| B. Current assets | 134 292,07 | 178 925,63 | 163 874,13 | 1 151,85 | 1 622,85 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | - |
| Total liabilities | 142 014,32 | 388 925,63 | 373 874,13 | 376 395,23 | 416 315,22 |
| A. Equity | -751 715,78 | 317 452,45 | 287 969,28 | 277 375,96 | 269 123,33 |
| B. Liabilities and provisions for liabilities | 893 730,10 | 71 473,18 | 85 904,85 | 99 019,27 | 147 191,89 |
| I. Long-term liabilities | - | 0,00 | - | - | - |
| II. Short-term liabilities | - | 71 473,18 | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.